Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Drops By 52.4%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 1,000 shares, a decline of 52.4% from the May 15th total of 2,100 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 7,500 shares, the days-to-cover ratio is currently 0.1 days.

BioNxt Solutions Stock Performance

BNXTF stock opened at $0.39 on Monday. The company’s 50 day moving average is $0.35 and its 200 day moving average is $0.32. The stock has a market cap of $45.62 million, a price-to-earnings ratio of -9.85 and a beta of 0.81. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.43.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.